Emicizumab Can Delay Immunosuppressive Tx in Acquired Hemophilia A

(MedPage Today) -- Early emicizumab (Hemlibra) prophylaxis alone prevented clinically relevant bleeds in patients with newly diagnosed acquired hemophilia A, while avoiding the infectious complications of immunosuppressive therapy in this vulnerable...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news